ExodusPoint Capital Management LP purchased a new stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 7,307 shares of the scientific and technical instruments company's stock, valued at approximately $773,000. ExodusPoint Capital Management LP owned 0.08% of Transcat as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Jones Financial Companies Lllp increased its stake in shares of Transcat by 686.7% in the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after acquiring an additional 309 shares in the last quarter. Morgan Dempsey Capital Management LLC bought a new stake in Transcat in the fourth quarter valued at $143,000. SG Americas Securities LLC acquired a new position in shares of Transcat during the fourth quarter valued at about $182,000. KLP Kapitalforvaltning AS acquired a new position in shares of Transcat during the fourth quarter valued at about $190,000. Finally, Captrust Financial Advisors bought a new position in shares of Transcat during the 3rd quarter worth about $201,000. 98.34% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on TRNS shares. HC Wainwright dropped their price target on Transcat from $126.00 to $106.00 and set a "buy" rating on the stock in a research note on Wednesday, January 29th. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. StockNews.com cut Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. Finally, Northland Securities restated a "market perform" rating and set a $85.00 price target (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $111.50.
Read Our Latest Report on TRNS
Transcat Stock Down 1.3 %
Shares of Transcat stock traded down $1.06 on Thursday, hitting $82.07. The company had a trading volume of 27,500 shares, compared to its average volume of 73,099. Transcat, Inc. has a 1 year low of $67.56 and a 1 year high of $147.12. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The stock has a 50 day moving average of $76.83 and a 200-day moving average of $96.22. The stock has a market capitalization of $763.94 million, a price-to-earnings ratio of 44.36 and a beta of 0.67.
Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same period last year, the company posted $0.56 earnings per share. As a group, sell-side analysts forecast that Transcat, Inc. will post 2.3 earnings per share for the current year.
Insider Activity
In other news, Director Craig D. Cairns acquired 1,200 shares of the firm's stock in a transaction on Friday, January 31st. The stock was purchased at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the purchase, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. This represents a 169.01 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.30% of the stock is currently owned by corporate insiders.
About Transcat
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Stories

Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.